Global Antiviral Drugs Market Size, Trends & Growth Opportunity, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Type (Branded, Generics), By Application, and Forecast

Best Price Guarantee	Publisher	Published Date	SKU
from $3,950	QualiKet Research	December, 2022	QUA17624138

Best Price Guarantee
Price	from $3,950
Publisher	QualiKet Research
Published Date	December, 2022
SKU	QUA17624138

Global Antiviral Drugs Market Size, Trends & Growth Opportunity, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Type (Branded, Generics), By Application, and Forecast till 2027.

Global Antiviral Drugs Market

The global Antiviral Drugs Market was valued at USD 63.5 billion in 2021 which expected to reach USD 64.0 billion by 2027 at a CAGR 1% from 2021-2027.

The Qualiket Research offers in-depth analysis, revenue details, and other important information regarding the Antiviral Drugs Market, and the various trends, drivers, restraints. A top-down & bottom-up approaches were employed in the preparation of the report on Antiviral Drugs Market. The overall report has been sectioned into an overview of the Antiviral Drugs Market, segmental outline, regional analysis, competitive dashboard, and the recent market updates. The Antiviral Drugs Market overview has been categorized into market statistics as well as the market highlights. Proficient analysts applied modern research methodologies for extensive primary & secondary research on the Antiviral Drugs Market.

The market statistics segment briefs on the forecasted CAGR the Antiviral Drugs Market is anticipated to register over the review period and the valuation it can attain by the end year. The market highlights details boosters and restraints, which can influence the target market growth over the forecast period. Skilled market analysts have meticulously worked on the evolution of the Antiviral Drugs Market and have identified the recent trends reinforcing the Antiviral Drugs Market growth. They have also spotted every opportunity based on that the market can capitalize

The market overview was noted on a zero-deviation approach & have maintained excellent quality research techniques throughout the Antiviral Drugs Market analysis. The segmental outline targets facets of the Antiviral Drugs Market. The regional analysis of the Antiviral Drugs Market provides an idea regarding the regional progress of the Antiviral Drugs Market as well as the identification of growth windows. In addition, the key vendors of the Antiviral Drugs Market have been segregated on a regional basis. Interviews with key people of the Antiviral Drugs Market and other credible sources like whitepaper are referred for designing the key operating players section. Furthermore, finally, the Antiviral Drugs Market update section mentions the recent key developments in the Antiviral Drugs Market

The report also helps in understanding Antiviral Drugs Market dynamics, structure by analyzing the market segments and projects the Antiviral Drugs Market. Overall representation of competitive analysis of key operating players by financial position, Product portfolio, growth strategies, as well as the regional presence in the Antiviral Drugs Market make the report investor’s guide.

Key Players:

The key players profiled in the Leavening Agents market report Gilead Sciences, Inc.; GlaxoSmithKline plc.; F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Merck & Co., Inc.; Johnson & Johnson Services, Inc.; Cipla Inc.; Aurobindo Pharma; Dr. Reddy’s Laboratories Ltd.

Market Taxonomy

By Drug Class

DNA Polymerase Inhibitors

Reverse Transcriptase Inhibitors

Protease Inhibitors

Neuraminidase Inhibitors

Others

By Type

Branded

Generics

By Application

HIV

Hepatitis

Herpes

Influenza

Others

By Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa

1 Introduction: 1.1 Objective of the Study; 1.2 Market definition; 1.3 Market Scope
2 Research Methodology: 2.1 Data Mining; 2.2 Validation; 2.3 Primary Interviews; 2.4 List of Data Sources
3 Executive Summary
4 Global Antiviral Drugs Market Outlook: 4.1 Overview; 4.2 Market Dynamics; 4.2.1 Drivers; 4.2.2 Restraints; 4.2.3 Opportunities; 4.3 Porters Five Force Model; 4.4 Value Chain Analysis
5 Global Antiviral Drugs Market, By Drug Class: 5.1 Y-o-Y Growth Comparison, By Drug Class; 5.2 Global Antiviral Drugs Market Share Analysis, By Drug Class; 5.3 Global Antiviral Drugs Market Size and Forecast, By Drug Class; 5.3.1 DNA Polymerase Inhibitors; 5.3.2 Reverse Transcriptase Inhibitors; 5.3.3 Protease Inhibitors; 5.3.4 Neuraminidase Inhibitors; 5.3.5 Others
6 Global Antiviral Drugs Market, By Type: 6.1 Y-o-Y Growth Comparison, By Type; 6.2 Global Antiviral Drugs Market Share Analysis, By Type; 6.3 Global Antiviral Drugs Market Size and Forecast, By Type; 6.3.1 Branded; 6.3.2 Generics
7 Global Antiviral Drugs Market, By Application: 7.1 Y-o-Y Growth Comparison, By Application; 7.2 Global Antiviral Drugs Market Share Analysis, By Application; 7.3 Global Antiviral Drugs Market Size and Forecast, By Application; 7.3.1 HIV; 7.3.2 Hepatitis; 7.3.3 Herpes; 7.3.4 Influenza; 7.3.5Others
8 Global Antiviral Drugs Market, By Region: 8.1 Global Antiviral Drugs Market Share Analysis, By Region; 8.2 Global Antiviral Drugs Market Share Analysis, By Region; 8.3 Global Antiviral Drugs Market Size and Forecast, By Region
9 North America Antiviral Drugs Market Analysis and Forecast (2021-2027): 9.1 Introduction; 9.2 North America Antiviral Drugs Market Share Analysis, By Drug Class; 9.3 North America Antiviral Drugs Market Size and Forecast, By Type; 9.4 North America Antiviral Drugs Market Size and Forecast, By Application; 9.6 North America Antiviral Drugs Market Size and Forecast, By Country; 9.7.1 U.S.; 9.7.2 Canada; 9.7.3 Mexico
10 Europe Antiviral Drugs Market Analysis and Forecast (2021-2027): 10.1 Introduction; 10.2 Europe Antiviral Drugs Market Share Analysis, By Drug Class; 10.3 Europe Antiviral Drugs Market Size and Forecast, By Type; 10.4 Europe Antiviral Drugs Market Size and Forecast, By Application; 10.6 Europe Antiviral Drugs Market Size and Forecast, By Country; 10.6.1 Germany; 10.6.2 France; 10.6.3 UK; 10.6.4. Rest of Europe
11 Asia Pacific Antiviral Drugs Market Analysis and Forecast (2021-2027): 11.1 Introduction; 11.2 Asia Pacific Antiviral Drugs Market Share Analysis, By Drug Class; 11.3 Asia Pacific Antiviral Drugs Market Size and Forecast, By Type; 11.4 Asia Pacific Antiviral Drugs Market Size and Forecast, By Application; 11.6 Asia Pacific Antiviral Drugs Market Size and Forecast, By Country; 11.6.1 China; 11.7.2 Japan; 11.8.3 India; 11.8.4. Rest of Asia Pacific
12 Latin America Antiviral Drugs Market Analysis and Forecast (2021-2027): 12.1 Introduction; 12.2 Latin America Antiviral Drugs Market Share Analysis, By Drug Class; 12.3 Latin America Antiviral Drugs Market Size and Forecast, By Type; 12.4 Latin America Antiviral Drugs Market Size and Forecast, By Application; 12.6 Latin America Antiviral Drugs Market Size and Forecast, Country; 12.7.1. Brazil; 12.8.2. Rest of Latin America
13 Middle East Antiviral Drugs Market Analysis and Forecast (2021-2027): 13.1 Introduction; 13.2 Middle East Antiviral Drugs Market Share Analysis, By Drug Class; 13.3 Middle East Antiviral Drugs Market Size and Forecast, By Type; 13.4 Middle East Antiviral Drugs Market Size and Forecast, By Application; 13.6 Middle East Antiviral Drugs Market Size and Forecast, By Country; 13.7.1. Saudi Arabia; 13.8.2. UAE; 13.8.3. Egypt; 13.9.4. Kuwait; 13.10.5. South Africa
14 Competitive Analysis: 14.1 Competition Dashboard; 14.2 Market share Analysis of Top Vendors; 14.3 Key Development Strategies
15 Company Profiles: 15.1 Gilead Sciences, Inc; 15.1.1 Overview; 15.1.2 Drug Classs; 15.1.3 Key Financials; 15.1.4 Business Segment & Geographic Overview; 15.1.5 Key Market Developments; 15.1.6 Key Strategies; 15.2. GlaxoSmithKline plc; 15.2.1 Overview; 15.2.2 Drug Classs; 15.2.3 Key Financials; 15.2.4 Business Segment & Geographic Overview; 15.2.5 Key Market Developments; 15.2.6 Key Strategies; 15.3. F. Hoffmann-La Roche Ltd; 15.3.1 Overview; 15.3.2 Drug Classs; 15.3.3 Key Financials; 15.3.4 Business Segment & Geographic Overview; 15.3.5 Key Market Developments; 15.3.6 Key Strategies; 15.4 AbbVie Inc; 15.4.1 Overview; 15.4.2 Drug Classs; 15.4.3 Key Financials; 15.4.4 Business Segment & Geographic Overview; 15.4.5 Key Market Developments; 15.4.6 Key Strategies; 15.5 Merck & Co., Inc; 15.5.1 Overview; 15.5.2 Drug Classs; 15.5.3 Key Financials; 15.5.4 Business Segment & Geographic Overview; 15.5.5 Key Market Developments; 15.5.6 Key Strategies; 15.6 Johnson & Johnson Services, Inc.; 15.6.1 Overview; 15.6.2 Drug Classs; 15.6.3 Key Financials; 15.6.4 Business Segment & Geographic Overview; 15.6.5 Key Market Developments; 15.6.6 Key Strategies; 15.7 Cipla Inc; 15.7.1 Overview; 15.7.2 Drug Classs; 15.7.3 Key Financials; 15.7.4 Business Segment & Geographic Overview; 15.7.5 Key Market Developments; 15.7.6 Key Strategies; 15.8 Aurobindo Pharma; 15.8.1 Overview; 15.8.2 Drug Classs; 15.8.3 Key Financials; 15.8.4 Business Segment & Geographic Overview; 15.8.5 Key Market Developments; 15.8.6 Key Strategies; 15.9 Dr. Reddy’s Laboratories Ltd; 15.9.1 Overview; 15.9.2 Drug Classs; 15.9.3 Key Financials; 15.9.4 Business Segment & Geographic Overview; 15.9.5 Key Market Developments; 15.9.6 Key Strategies

Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others),

May, 2022 | Published by: Coherent Market Insights | USD $4,500
Antiviral Therapeutics Market by Drug (Hepatitis Antiviral Drug, Herpes Antiviral Drug, HIV Antiviral Drug), Therapy (DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Protease Inhibitors), Distribution - Global Forecast 2024-2030

June, 2024 | Published by: 360iResearch | USD $4,949
Global Antiviral Therapeutics Market Size Study, By Drug (Hepatitis, Herpes, HIV, Influenza), By Therapy (DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Protease Inhibitors, Reverse Transcriptase Inhibitors), By Distribution Channel (Hospital Pharmacy, Independent Pharmacy & Drug Store, Online Pharmacy), and Regional Forecasts 2022-2032

July, 2024 | Published by: Bizwit Research & Consulting | USD $4,950
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

May, 2024 | Published by: Coherent Market Insights | USD $4,500
Antiviral Drugs Market Size, Trends, Analysis, and Outlook By Type (Branded, Generics), By Class, DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others), by Region, Country, Segment, and Companies, 2024-2030

March, 2024 | Published by: VPA Research | USD $3,980
Global Oral Antiviral Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Drug Class (Protease Inhibitors (PIs), Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors and Other Drug Classes), Indication, Distribution Channel, Region, By Country: 2020-2030

July, 2024 | Published by: Azoth Analytics | USD $2,450

PDF E-mail From Publisher:	$3,950
Global Site License Fulfilled by Publisher:	$5,950

Global Antiviral Drugs Market Size, Trends & Growth Opportunity, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Type (Branded, Generics), By Application, and Forecast

Research Assistance

Other tasks

Global Antiviral Drugs Market Size, Trends & Growth Opportunity, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Type (Branded, Generics), By Application, and Forecast

Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others),

Antiviral Therapeutics Market by Drug (Hepatitis Antiviral Drug, Herpes Antiviral Drug, HIV Antiviral Drug), Therapy (DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Protease Inhibitors), Distribution - Global Forecast 2024-2030

Research Assistance

Other tasks